Triple-action of the standardized antidiabetic polyherbal extract; Synacinn™ through upregulation of GLUT4 and inhibition of DPP(IV), α-amylase, and α-glucosidase activity.

INTRODUCTION: Synacinn™ is a standardized polyherbal supplement for diabetes mellitus which is formulated from Andrographis paniculata, Curcuma xanthorrhiza, Cinnamomum zeylanicum, Eugenia polyantha, and Orthosiphon stamineous. MATERIALS AND METHODS: This study aimed to elucidate the antidiabetic potential of Synacinn™ on three specific actions, including 1) the insulin sensitivity and glucose transport on dexamethasone-induced insulin-resistance 3T3-L1 adipocytes, 2) the inhibitory capacity on postprandial enzyme activity (α-amylase and α-glucosidase), and 3) the inhibitory activity of hepatic DPP(IV) enzyme. RESULTS: Results showed that insulin resistance of 3T3-L1 adipocytes may be developed by prolonging the exposure of 1µg/ml of dexamethasone for >48 hours. The insulinresistance condition was minimized by the treatment of 10 µg/ml of Synacinn™ which significantly improved the insulin-stimulated glucose utilization by 10.6%. Meanwhile, insulin-stimulated glucose utilization in normal adipocytes was also attenuated by 9.2%. At the cellular level, Synacinn™ attenuated glucose utilization mainly by upregulating GLUT4 protein expression by 1.71 fold. Additionally, Synacinn™ is a potent inhibitor for the activity of α-amylase and α-glucosidase with IC50 of 0.467 mg/mL and 0.245 mg/mL, respectively. Synacinn™ also controlled the glycemic index through inhibition of hepatic DPP(IV) enzyme with IC50 of 1.11 mg/mL. CONCLUSION: Results suggested that Synacinn™ reduced diabetes mellitus through sensitizing the cellular glucose utilization, reducing the postprandial carbohydrate degradation, and inhibiting the hepatic DPP(IV) enzyme function.

Potential Health Benefits of Deep Sea Water: A Review.

Deep sea water (DSW) commonly refers to a body of seawater that is pumped up from a depth of over 200 m. It is usually associated with the following characteristics: low temperature, high purity, and being rich with nutrients, namely, beneficial elements, which include magnesium, calcium, potassium, chromium, selenium, zinc, and vanadium. Less photosynthesis of plant planktons, consumption of nutrients, and organic decomposition have caused lots of nutrients to remain there. Due to this, DSW has potential to become a good source for health. Research has proven that DSW can help overcome health problems especially related to lifestyle-associated diseases such as cardiovascular disease, diabetes, obesity, cancer, and skin problems. This paper reviews the potential health benefits of DSW by referring to the findings from previous researches.

Efficacy of papain-based wound cleanser in promoting wound regeneration.

A new invention, papain-based wound cleanser is formulated by incorporating papain, a proteolytic enzyme extracted from Carica papaya into the formulation. This cleanser is invented to simplify the methods in wound management by combining wound cleansing and wound debridement using a single formulation. This study describes the preparation and preclinical study of papain-based wound cleanser in accelerating wound healing. In this study, papain-based wound cleanser was used to treat wound incision on Sprague-Dawley rats while distilled water and Betadine were used as negative and positive control. Twenty-seven clinically healthy white rats were randomly divided into three groups and treated accordingly until the 21st day post-incision. Wound reduction rates and histological analysis were obtained to asses the healing pattern. Rats treated with papain-based wound cleanser showed a progressive wound healing based on the wound reduction rates and histological analysis when compared with rats treated with distilled water and Betadine. Better collagen deposition and presence of skin organelles in rats treated with papain-based wound cleanser demonstrated its efficacy in promoting wound healing. In addition to its wound healing effect, papain-based wound cleanser is also integrated with antibacterial properties which make it a complete package for wound management. However, further studies should be carried out to ensure its safety for human usage.

Glycosylation of an immunoglobulin produced from a murine hybridoma cell line: the effect of culture mode and the anti-apoptotic gene, bcl-2.

The impact of bcl-2 over-expression on the glycosylation pattern of an antibody produced by a bcl-2 transfected hybridoma cell line (TB/C3.bcl-2) was investigated in suspension batch, continuous and high cell density culture (Flat hollow fibre, Tecnomouse system). In all culture modes bcl-2 over-expression resulted in higher cell viability. Analysis of the glycans from the IgG of batch cultures showed that >95% of the structures were neutral core fucosylated asialo biantennary oligosaccharides with variable terminal galactosylation (G0f, G1f and G2f) consistent with previous analysis of glycans from the conserved site at Asn-297 of the IgG protein. The galactosylation index (GI) was determined as an indicator of the glycan profile (=(G2 + 0.5* G1)/(G0 + G1 + G2)). GI values in control cultures were comparable to bcl-2 cultures during exponential growth (0.53) but declined toward the end of the culture when there was a loss in cell viability. Low dilution rates in chemostat culture were associated with reduced galactosylation of the IgG glycans in both cell lines. However, at the higher dilution rates the GI for IgG was consistently higher in the TB/C3.bcl-2 cultures. In the hollow fibre bioreactor the galactosylation of the IgG glycans was considerably lower than in suspension batch or continuous cultures with GI values averaging 0.38. Similar low galactosylation values have been found previously for high density cell cultures and these are consistent with the low values obtained when the dissolved oxygen level is maintained at a low value (10%) in controlled suspension cultures of hybridomas.